Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 16/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.48 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.47 |
| ▸ | ACACB | O00763 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2876392 | 0.81 | MCHR1 (0.60) | MCHR1KCNH2MAPK14 | |
| SCHEMBL10205660 | 0.81 | MCHR1 (0.69) | MCHR1KCNH2MAPK14 | |
| SCHEMBL2876286 | 0.80 | MCHR1 (0.59) | MCHR1KCNH2MAPK14 | |
| SCHEMBL2879722 | 0.77 | MCHR1 (0.66) | MCHR1KCNH2 | |
| SCHEMBL1364816 | 0.77 | MCHR1 (0.82) | MCHR1KCNH2MAPK14 | |
| SCHEMBL1366576 | 0.76 | MCHR1 (1.00) | MCHR1KCNH2 | |
| SCHEMBL2879682 | 0.75 | MCHR1 (0.63) | MCHR1KCNH2 | |
| SCHEMBL2882223 | 0.75 | MCHR1 (0.66) | MCHR1KCNH2 | |
| SCHEMBL1365635 | 0.75 | MCHR1 (0.79) | MCHR1KCNH2MAPK14 | |
| SCHEMBL2881740 | 0.74 | MCHR1 (0.81) | MCHR1KCNH2MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100216758-A1 | Pyridone Compounds | MSD K.K. (JP) | 2010-08-26 | — | — | US | disclosed |
| EP-1916239-A1 | PYRIDONE COMPOUND | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216758-A1 | Pyridone Compounds | NPY1R, MC5R, MC1R | MCHR1 4/4885KCNH2 2487/4885MAPK14 2278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.